Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment
作者:Yong Rao、Hong Liu、Lin Gao、Hong Yu、Tian-Miao Ou、Jia-Heng Tan、Shi-Liang Huang、Hong-Gen Wang、Ding Li、Lian-Quan Gu、Ji-Ming Ye、Zhi-Shu Huang
DOI:10.1021/acs.jmedchem.5b01566
日期:2015.12.10
Our recent study has shown that the natural product bouchardatine (1) can reduce the triglyceride (TG) content in 3T3-L1 adipocytes (EC50 approximate to 25 mu M). Here, we synthesized two series of compounds by introducing amine side chains at the 5 or 8 position of 1 and evaluated the lipid-lowering activity of derivatives. It was found that some of the compounds had significant lipid-lowering effects, and the most active compound 3d showed better activity (EC50 = 0.017 mu M) than 2 (EC50 = 0.086 mu M), a compound reported by us. Further, the mechanism studies revealed that 3d blocked TG accumulation via activation of the LKB1-AMPK signaling pathway, efficiently down-regulating the expression of key regulators of adipogenesis/lipogenesis. Cell uptake assay and confocal imaging of 3d in cells indicated that compound 3d had favorable cell permeability. Our results suggest that 3d may be a promising agent for the treatment of obesity and related metabolic disorders.